105 related articles for article (PubMed ID: 11786096)
1. Down-regulation of lipoprotein lipase and VLDL receptor in rats with focal glomerulosclerosis.
Sato T; Liang K; Vaziri ND
Kidney Int; 2002 Jan; 61(1):157-62. PubMed ID: 11786096
[TBL] [Abstract][Full Text] [Related]
2. Protein restriction and AST-120 improve lipoprotein lipase and VLDL receptor in focal glomerulosclerosis.
Sato T; Liang K; Vaziri ND
Kidney Int; 2003 Nov; 64(5):1780-6. PubMed ID: 14531811
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis.
Vaziri ND; Sato T; Liang K
Kidney Int; 2003 May; 63(5):1756-63. PubMed ID: 12675851
[TBL] [Abstract][Full Text] [Related]
4. Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure.
Liang K; Oveisi F; Vaziri ND
Kidney Int; 1998 Mar; 53(3):626-30. PubMed ID: 9507207
[TBL] [Abstract][Full Text] [Related]
5. AT-1 receptor blockade prevents proteinuria, renal failure, hyperlipidemia, and glomerulosclerosis in the Imai rat.
Rodríguez-Iturbe B; Sato T; Quiroz Y; Vaziri ND
Kidney Int; 2004 Aug; 66(2):668-75. PubMed ID: 15253721
[TBL] [Abstract][Full Text] [Related]
6. Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome.
Shearer GC; Stevenson FT; Atkinson DN; Jones H; Staprans I; Kaysen GA
Kidney Int; 2001 Jan; 59(1):179-89. PubMed ID: 11135070
[TBL] [Abstract][Full Text] [Related]
7. Gene expression of lipoprotein lipase in experimental nephrosis.
Liang K; Vaziri ND
J Lab Clin Med; 1997 Oct; 130(4):387-94. PubMed ID: 9358077
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of VLDL receptor expression in chronic experimental renal failure.
Vaziri ND; Liang K
Kidney Int; 1997 Mar; 51(3):913-9. PubMed ID: 9067930
[TBL] [Abstract][Full Text] [Related]
9. Effect of diet on adipose tissue and skeletal muscle VLDL receptor and LPL: implications for obesity and hyperlipidemia.
Roberts CK; Barnard RJ; Liang KH; Vaziri ND
Atherosclerosis; 2002 Mar; 161(1):133-41. PubMed ID: 11882325
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure.
Vaziri ND; Liang K
Kidney Int; 1996 Dec; 50(6):1928-35. PubMed ID: 8943476
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of hepatic Acyl CoA: Diacylglycerol acyltransferase-1 (DGAT-1) expression in nephrotic syndrome.
Vaziri ND; Kim CH; Phan D; Kim S; Liang K
Kidney Int; 2004 Jul; 66(1):262-7. PubMed ID: 15200432
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of hypertriglyceridemia in Dahl salt-sensitive rats, an animal model of spontaneous nephrotic syndrome.
Hirano T; Ebara T; Furukawa S; Nagano S; Takahashi T
Metabolism; 1994 Feb; 43(2):248-56. PubMed ID: 8121310
[TBL] [Abstract][Full Text] [Related]
13. Proteinuria and plasma compositional changes contribute to defective lipoprotein catabolism in the nephrotic syndrome by separate mechanisms.
Shearer GC; Kaysen GA
Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S119-22. PubMed ID: 11158876
[TBL] [Abstract][Full Text] [Related]
14. Catabolic defect of triglyceride is associated with abnormal very-low-density lipoprotein in experimental nephrosis.
Furukawa S; Hirano T; Mamo JC; Nagano S; Takahashi T
Metabolism; 1990 Jan; 39(1):101-7. PubMed ID: 2294370
[TBL] [Abstract][Full Text] [Related]
15. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes.
Weinstock PH; Bisgaier CL; Aalto-Setälä K; Radner H; Ramakrishnan R; Levak-Frank S; Essenburg AD; Zechner R; Breslow JL
J Clin Invest; 1995 Dec; 96(6):2555-68. PubMed ID: 8675619
[TBL] [Abstract][Full Text] [Related]
16. Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency.
Yagyu H; Lutz EP; Kako Y; Marks S; Hu Y; Choi SY; Bensadoun A; Goldberg IJ
J Biol Chem; 2002 Mar; 277(12):10037-43. PubMed ID: 11790777
[TBL] [Abstract][Full Text] [Related]
17. Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels.
Wang L; Shearer GC; Budamagunta MS; Voss JC; Molfino A; Kaysen GA
Kidney Int; 2012 Nov; 82(9):990-9. PubMed ID: 22785171
[TBL] [Abstract][Full Text] [Related]
18. Renal lesions of hyperlipidemic Imai rats: a spontaneous animal model of focal glomerulosclerosis.
Yoshikawa Y; Yamasaki K
Nephron; 1991; 59(3):471-6. PubMed ID: 1758540
[TBL] [Abstract][Full Text] [Related]
19. Role of intrarenal angiotensin system activation, oxidative stress, inflammation, and impaired nuclear factor-erythroid-2-related factor 2 activity in the progression of focal glomerulosclerosis.
Kim HJ; Sato T; Rodríguez-Iturbe B; Vaziri ND
J Pharmacol Exp Ther; 2011 Jun; 337(3):583-90. PubMed ID: 21357516
[TBL] [Abstract][Full Text] [Related]
20. Association between very-low-density lipoprotein and glomerular injury in obese Zucker rats.
Kamanna VS; Kirschenbaum MA
Am J Nephrol; 1993; 13(1):53-8. PubMed ID: 8322840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
